Greater Cancer Risk Linked to Certain Oral DMTs & Supplements for MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how S1P receptor modulators such as Mayzent and Gilenya may be associated with a greater likelihood of skin cancer. He also reads “The Supplements of Mice and Men”, from John Connor's regular column "Fall Down, Get Up Again".

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/